Comparison results
| Results: Differences General | ✘R09.1 | ✘A54.5 | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | 81% | — | ||||||||||
| shortness of breath when moving | 79% | — | ||||||||||
| dyspnea | 70% | — | ||||||||||
| shortness of breath when talking | 64% | — | ||||||||||
| there is heart failure | 64% | — | ||||||||||
| heart failure | 64% | — | ||||||||||
| shortness of breath during physical exertion | 59% | — | ||||||||||
| inflammation | 49% | — | ||||||||||
| increase in creatinine | 47% | — | ||||||||||
| metastases | 44% | — | ||||||||||
| increased alt | 42% | — | ||||||||||
| chronic heart failure | 42% | — | ||||||||||
| sputum with blood | 40% | — | ||||||||||
| increased ESR | 38% | — | ||||||||||
| mchc reduced | 38% | — | ||||||||||
| no strength | 36% | — | ||||||||||
| increased ast | 35% | — | ||||||||||
| swelling of the legs | 35% | — | ||||||||||
| metabolic syndrome | 32% | — | ||||||||||
| ascites | 29% | — | ||||||||||
| pleurisy | 17% | — | ||||||||||
| calcification | 12% | — | ||||||||||
Instructions
Video 
|
